• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Data Market
Data News
Data Stocks
  • Data Market
  • Data News
  • Data Stocks

Viratech Acquires 50% of Newswire.net, in Spin Off of Cancer.im, Inc.

Pia Rivera
Mar. 07, 2017 08:30AM PST
Data Investing

Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc. As quoted in the press release: “The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi …

Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc.
As quoted in the press release:

“The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi perspective point of view via verified and vetted social collaboration,” stated Fred Schiemann CEO of Viratech. “With this announcement we have hit a milestone; first with this transaction, we gain a partner in Newswire, where we hope to harness Newswire’s distribution platform to promote our News as a Utility (NaaU) Engine.
“Second, we have achieved our Minimum Viable Product (MVP) threshold, on developing our first SNAP to reside on the www.cancer.imdomain on March 15, 2017. With the sale of Cancer.im, Inc. property, Viratech can now focus on developing new SNAP’s in the other health verticals. That is the beauty of software, once the infrastructure is built, replication into other health verticals becomes easier.”
“Viratech has engineered an amazing tool-set for the cancer community, and starting March 15, 2017, I am excited that our team will be able to curate, manage and produce some of the most relevant content on the web pertaining to cancer research,” stated Chris Ryan CEO of Cancer.im, Inc.

Click here for the full press release. 

cancer research
The Conversation (0)

Go Deeper

AI Powered
Senior woman doing exercises alongside closeup of DNA.

5 US Longevity and Anti-aging Stocks to Watch

A floating DNA double helix above a hand with a blue background.

Top 4 NASDAQ Genetics Stocks (Updated January 2026)

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Data Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES